Top 5 Stock Picks of Jacob Doft’s Highline Capital Management

2. Passage Bio, Inc. (NASDAQ:PASG)

Highline Capital Management’s Stake Value: $13,207,000

Percentage of Highline Capital Management’s 13F Portfolio: 11.02%

Number of Hedge Fund Holders: 16

Passage Bio, Inc. (NASDAQ:PASG) is a genetics medicine company from Philadelphia, offering therapeutics for central nervous system disorders. Passage Bio, Inc. (NASDAQ:PASG) is a notable stock in Doft’s portfolio as of June this year, with Highline Capital Management owning 997,506 shares in the healthcare company. With an approximate stake value of $13.2 million, Passage Bio, Inc. (NASDAQ:PASG) represents  11.02% of Highland Capital’s Q2 portfolio. 

Passage Bio, Inc. (NASDAQ:PASG) announced on November 4 earnings for the third quarter. The EPS for Q3 totaled -$0.77, beating estimates by $0.10. 

As of the second quarter of 2021, 16 hedge funds in the database of Insider Monkey’s elite funds were long Passage Bio, Inc. (NASDAQ:PASG), up from 14 in the preceding quarter.